[메가경제=양대선 기자] Pharma Robotics, an AI-powered medical robotics company specializing in medicine dispensing robots, took first place with its automated injection drug dispensing robots at the open IR pitching contest hosted by Seoul Startup Hub.
 |
| ▲ 사진=파마로보틱스 |
An open IR pitching event held at Seoul Startup Hub Scaleup Center on April 28 was designed to help promising Seoul-based startups to secure private investment. A panel of venture capitalists, the partner of Scaleup Center, evaluated ten startups from Seoul Startup Hub branches in Gongdeok, Seonsu, and Dongjak. As a high-scoring company, Pharma Robotics was selected to participate in the pitching session at ‘Try Everything 2026’, scheduled for September 9 to 10.
The robot introduced at the session is a smart robot platform equipped with precision actuator control technology and its proprietary injection dispensing algorithm. It features a one-stop process, ranging from hospital electronic prescriptions to the recognition and dispensing of medicines.
In February, Pharma Robotics successfully completed the development of its first-generation automated injection drug dispensing robot prototype. The robot has drawn attention for ensuring practical safety upon hospital deployment, featuring a laminar flow design that utilizes HEPA filters in full compliance with injection drug dispensing guidelines.
Currently, Pharma Robotics is making a full-fledged effort to accelerate the adoption of its advanced technology. This coming July and August, the company sets to conduct large-scale usability testing targeting end-users, including nursing staff and pharmacists at major domestic university hospitals. The goal is to optimize the UI/UX by incorporating direct feedback from these clinical sites.
Yoo Je-cheong, the CEO of Pharma Robotics noted, “Winning the IR contest hosted by Seoul Startup Hub validates our technology’s value and recognizes our genuine commitment to solving critical issues at medical sites. Moving beyond mere numerical achievements, our ultimate goal is to protect healthcare professionals from hazardous environments and ensure patient safety by drastically reducing dispensing errors.
Meanwhile, the company plans to expand its production and research facilities in the Jeonju region, accelerating its market entry strategy for both domestic and international hospital markets.
[저작권자ⓒ 메가경제. 무단전재-재배포 금지]
